Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Molecular and biochemical parasitology (Print)

• Publication date

  1998-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0166-6851(98)00037-1PMID 9662705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Trypanosoma cruzi strains partition into two groups based on the structure and function of the spliced leader RNA and rRNA gene promoters.

  1997cited by this paper
• Detection of RAPD markers correlated with chloroquine resistance in Plasmodium falciparum.

  1997cited by this paper
• Characterization of Trypanosoma cruzi strains isolated from chronic chagasic patients, triatomines and opossums naturally infected from the State of Rio Grande do Sul, Brazil.

  1997cited by this paper
• Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology.

  1997cited by this paper
• Molecular characterization of a P-glycoprotein-related tcpgp2 gene in Trypanosoma cruzi.

  1996cited by this paper
• Characterization of Trypanosoma cruzi populations by zymodemes: correlation with clinical picture.

  1996cited by this paper
• DNA markers define two major phylogenetic lineages of Trypanosoma cruzi.

  1996cited by this paper
• Intraspecific polymorphisms of Eimeria species due to resistance against anticoccidial drugs

  1996cited by this paper
• Multidrug resistance and P-glycoproteins in parasitic protozoa

  1995cited by this paper
• Trypanosoma cruzi: sequence of the ATP-binding site of a P-glycoprotein gene.

  1994cited by this paper
• Molecular characterization and overexpression of the hypoxanthine-guanine phosphoribosyltransferase gene from Trypanosoma cruzi.

  1994cited by this paper
• Genetic and population study of a Y-linked tetranucleotide repeat DNA polymorphism with a simple non-isotopic technique

  1993cited by this paper
• DNA Fingerprinting of Trypanosoma vivax Isolates Rapidly Identifies Intraspecific Relationships

  1993cited by this paper
• Genetic characterization of six parasitic protozoa: parity between random-primer DNA typing and multilocus enzyme electrophoresis.

  1993cited by this paper
• Random amplified polymorphic DNA analysis of Trypanosoma cruzi strains.

  1993cited by this paper
• The challenge of Chagas' disease chemotherapy: an update of drugs assayed against Trypanosoma cruzi.

  1993cited by this paper
• DNA fingerprinting of Trypanosoma cruzi: a new tool for characterization of strains and clones.

  1992cited by this paper
• The importance of the opossum (Didelphis albiventris) as a reservoir for Trypanosoma cruzi in Bambuí, Minas Gerais State.

  1991cited by this paper
• Characterization of Trypanosoma cruzi from Argentina by electrophoretic zymograms.

  1991cited by this paper
• Changes in the isoenzyme and kinetoplast DNA patterns of Trypanosoma cruzi strains induced by maintenance in mice.

  1990cited by this paper
• Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum

  1990cited by this paper
• Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.

  1987cited by this paper
• Epidemiology of Chagas' disease in northern Chile: isozyme profiles of Trypanosoma cruzi from domestic and sylvatic transmission cycles and their association with cardiopathy.

  1987cited by this paper
• Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central Brazil.

  1986cited by this paper
• Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types.

  1985cited by this paper
• A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents.

  1984cited by this paper
• Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles.

  1980cited by this paper
• Isozymic heterogeneity of Trypanosoma cruzi in the first autochthonous patients with Chagas' disease in Amazonian Brazil

  1978cited by this paper
• [Clinico-therapeutic trial with benzonidazole in Chagas' disease].

  1976cited by this paper
• Animal experimental investigation into the activity of nifurtimox against Trypanosoma cruzi.

  1972cited by this paper
• GROWTH AND DIFFERENTIATION IN TRYPANOSOMA CRUZI. I. ORIGIN OF METACYCLIC TRYPANOSOMES IN LIQUID MEDIA.

  1964cited by this paper
• Numerical Taxonomy

  1962cited by this paper
• Autoradiography of Bacteria and Streptomycetaceae by the Stripping Film Technique

  1962cited by this paper
• Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi.

  1962cited by this paper
• Measures of the Amount of Ecologic Association Between Species

  1945cited by this paper

• Resistance of companion animal parasites to antiparasitic drugs.

  2025cites this paper
• Expression Analysis of Thirteen Genes in Response to Nifurtimox and Benznidazole in Mexican Isolates of Trypanosoma cruzi by Digital PCR

  2025cites this paper
• Pharmacological inhibition of Trypanosoma cruzi aldo-keto reductase (TcAKR) and its effect on benznidazole resistance.

  2025cites this paper
• Dissimilar Trypanosoma cruzi genotype-specific serological profile assessed by Chagas-Flow ATE IgG1 upon benznidazole etiological treatment of chronic Chagas disease

  2024cites this paper
• Improving in vitro screening compounds anti-Trypanosoma cruzi by GFP-expressing parasites

  2024cites this paper
• Drug screening and development cascade for Chagas disease: an update of in vitro and in vivo experimental models

  2024cites this paper
• Tackling the Challenges of human Chagas Disease: a Comprehensive Review of Treatment Strategies in the Chronic Phase and Emerging Therapeutic Approaches.

  2024cites this paper
• New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes

  2024cites this paper
• From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease

  2023cites this paper
• Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?

  2023cites this paper
• Novel diamides inspired by protein kinase inhibitors as anti-Trypanosoma cruzi agents: in vitro and in vivo evaluations.

  2023cites this paper
• Intra-host Trypanosoma cruzi strain dynamics shape disease progression: the missing link in Chagas disease pathogenesis

  2023cites this paper
• Selected Aspects of the Analytical and Pharmaceutical Profiles of Nifurtimox.

  2023cites this paper
• Cannabis sativa: A look at protozoa, helminths, insect vectors, and pests.

  2023cites this paper
• The History of the ABC Proteins in Human Trypanosomiasis Pathogens

  2022cites this paper
• Effect of B-NIPOx in Experimental Trypanosoma cruzi Infection in Mice

  2022cites this paper
• Trypanosoma cruzi iron superoxide dismutases: insights from phylogenetics to chemotherapeutic target assessment

  2022cites this paper
• Trypanosoma cruzi Mitochondrial Peroxiredoxin Promotes Infectivity in Macrophages and Attenuates Nifurtimox Toxicity

  2022cites this paper
• Kinetic Characterization and Inhibition of Trypanosoma cruzi Hypoxanthine–Guanine Phosphoribosyltransferases

  2022cites this paper
• Drug Discovery and Development for Kinetoplastid Diseases

  2021cites this paper
• Genetic polymorphism of Trypanosoma cruzi bloodstream populations in adult chronic indeterminate Chagas disease patients from the E1224 clinical trial

  2021cites this paper
• The emerging paradigm of calcium homeostasis as a new therapeutic target for protozoan parasites

  2021cites this paper
• Design, Synthesis, and Evaluation of Substrate - Analogue Inhibitors of Trypanosoma cruzi Ribose 5-Phosphate Isomerase type B.

  2020cites this paper
• Thiol efflux mediated by an ABCC-like transporter participates for Trypanosoma cruzi adaptation to environmental and chemotherapeutic stresses

  2020cites this paper
• New Approaches for the Treatment of Chagas Disease.

  2020cites this paper
• Role of Nucleic Acid Amplification assays in monitoring treatment response in Chagas disease: Usefulness in clinical trials.

  2019cites this paper
• Hybrids of Cinchona Alkaloids and Bile Acids as Antiparasitic Agents Against Trypanosoma cruzi

  2019cites this paper
• Drug transporter and oxidative stress gene expression in human macrophages infected with benznidazole-sensitive and naturally benznidazole-resistant Trypanosoma cruzi parasites treated with benznidazole

  2019cites this paper
• Heterobimetallic nickel(II) and palladium(II) complexes derived from S-benzyl-N- (ferrocenyl)methylenedithiocarbazate: Trypanocidal activity and interaction with Trypanosoma cruzi Old Yellow Enzyme (TcOYE).

  2019cites this paper
• NANOCARRIERS FOR EFFECTIVE DELIVERY OF BENZNIDAZOLE AND NIFURTIMOX IN THE TREATMENT OF CHAGAS DISEASE: A REVIEW.

  2019cites this paper
• Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.

  2018cites this paper
• Synthèse et étude de l'activité anti-kinétoplastidés de nouvelles 8-nitroquinoléin-2(1H))-ones bioactivées par les nitroréductases de type 1

  2018cites this paper
• Drug Resistance in Trypanosoma brucei

  2017cites this paper
• Synthesis, anti-Trypanosoma cruzi activity and quantitative structure relationships of some fluorinated thiosemicarbazones

  2017cites this paper
• Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity.

  2017cites this paper
• Identification of Specific Inhibitors of Trypanosoma cruzi Malic Enzyme Isoforms by Target-Based HTS

  2017cites this paper
• Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors

  2017cites this paper
• Drug Resistance Assays for Parasitic Diseases

  2017cites this paper
• Aldo‐keto reductase and alcohol dehydrogenase contribute to benznidazole natural resistance in Trypanosoma cruzi

  2017cites this paper
• Trypanosoma cruzi I genotype among isolates from patients with chronic Chagas disease followed at the Evandro Chagas National Institute of Infectious Diseases (FIOCRUZ, Brazil).

  2017cites this paper
• Experimental and Clinical Treatment of Chagas Disease: A Review

  2017cites this paper
• Benznidazole affects expression of Th1, Th17 and Treg cytokines during acute experimental Trypanosoma cruzi infection

  2017cites this paper
• Molecular characterization of lipoamide dehydrogenase gene in Trypanosoma cruzi populations susceptible and resistant to benznidazole.

  2016cites this paper
• Current drug therapy and pharmaceutical challenges for Chagas disease.

  2016cites this paper
• The Role of Metabolomics in Antiparasitic Drug Discovery

  2016cites this paper
• Up-regulation of ATP-binding cassette transporters in the THP-1 human macrophage cell line by the antichagasic benznidazole

  2016cites this paper
• Molecular characterization of Cyclophilin (TcCyP19) in Trypanosoma cruzi populations susceptible and resistant to benznidazole.

  2015influential citation
• Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.

  2015cites this paper
• ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates.

  2015cites this paper
• Old and new challenges in Chagas disease.

  2015cites this paper
• Between a bug and a hard place: Trypanosoma cruzi genetic diversity and the clinical outcomes of Chagas disease

  2015cites this paper
• Designing and exploring active N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against three Trypanosoma cruzi strains more prevalent in Chagas disease patients.

  2015cites this paper
• A novel ABCG-like transporter of Trypanosoma cruzi is involved in natural resistance to benznidazole

  2015cites this paper
• Enantiomers of Nifurtimox Do Not Exhibit Stereoselective Anti-Trypanosoma cruzi Activity, Toxicity, or Pharmacokinetic Properties

  2015cites this paper
• Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles

  2014cites this paper
• Drug repurposing and human parasitic protozoan diseases

  2014cites this paper
• Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model

  2014cites this paper
• Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert

  2014cites this paper
• New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice.

  2014cites this paper
• Transition-state-guided drug design for treatment of parasitic neglected tropical diseases.

  2014cites this paper
• Experimental Chagas Disease Parenteral Dosage Form Is Efficacious in Sesquiterpene Lactone in Nanostructured

  2014cites this paper
• Sesquiterpene Lactone in Nanostructured Parenteral Dosage Form Is Efficacious in Experimental Chagas Disease

  2014cites this paper
• In vitro phenotypic screening of 7-chloro-4-amino(oxy)quinoline derivatives as putative anti-Trypanosoma cruzi agents.

  2014cites this paper
• Sequence variation in CYP51A from the Y strain of Trypanosoma cruzi alters its sensitivity to inhibition

  2014cites this paper
• In Vitro Imaging of Trypanosoma cruzi Host Infection Systems for Evaluation of Compound Activity

  2014cites this paper
• Drug Strategies Targeting CYP51 in Neglected Tropical Diseases

  2014cites this paper
• Estudo do mecanismo de resistência a compostos derivados da classe das tiossemicarbazonas em tripanosomatídeos, com ênfase na glicoproteína-P e na nitrorredutase do tipo I

  2014cites this paper
• Microsatellite and Mini-Exon Analysis of Mexican Human DTU I Trypanosoma cruzi Strains and Their Susceptibility to Nifurtimox and Benznidazole

  2013cites this paper
• Validation of N-myristoyltransferase as potential chemotherapeutic target in Chagas disease

  2013cites this paper
• In vivo susceptibility to benznidazole of Trypanosoma cruzi strains from the western Brazilian Amazon

  2013cites this paper
• Aromatic glycosyl disulfide derivatives: evaluation of their inhibitory activities against Trypanosoma cruzi.

  2013cites this paper
• Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.

  2013cites this paper
• UNIVERSIDADE FEDERAL DE UBERLÂNDIA INSTITUTO DE CIÊNCIAS BIOMÉDICAS PROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E ESTRUTURAL APLICADAS

  2013cites this paper
• Avaliação da atividade anti-Trypanosoma cruzi do derivado triazólico Ravuconazol utilizando o cão como modelo experimental.

  2013cites this paper
• Pyrimidine salvage and metabolism in kinetoplastid parasites

  2013cites this paper
• MECHANISMS OF RESISTANCE TO ANTIPARASITIC DRUGS IN TRYPANOSOMA CRUZI. CORRELATIONS BETWEEN GENOTYPE AND RESISTANCE

  2013cites this paper
• Identification Of Chemotherapeutic Agents Against Leishmaniasis And Chagas' Disease

  2013cites this paper
• Trypanosoma cruzi I and IV Stocks from Brazilian Amazon Are Divergent in Terms of Biological and Medical Properties in Mice

  2013cites this paper
• In Vitro and In Vivo Studies of the Antiparasitic Activity of Sterol 14α-Demethylase (CYP51) Inhibitor VNI against Drug-Resistant Strains of Trypanosoma cruzi

  2013cites this paper
• Ergosterol Biosynthesis for the Specific Treatment of Chagas Disease: From Basic Science to Clinical Trials

  2013cites this paper
• Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population

  2012cites this paper
• Molecular and functional characterization of the ceramide synthase from Trypanosoma cruzi.

  2012cites this paper
• Instituto Oswaldo Cruz

  2012cites this paper
• Molecular characterization of the hexose transporter gene in benznidazole resistant and susceptible populations of Trypanosoma cruzi

  2012cites this paper
• Therapy of Chagas Disease: Implications for Levels of Prevention

  2012cites this paper
• Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.

  2012cites this paper
• Sensibilidad al benzonidazol de cepas de Trypanosoma cruzi sugiere la circulación de cepas naturalmente resistentes en Colombia

  2012cites this paper
• [Evaluation of the inhibitory effect of extracts from leaves of Renealmia alpinia Rottb. Maas (Zingiberaceae) on the venom of Bothrops asper (mapaná)].

  2012cites this paper
• The level of ascorbate peroxidase is enhanced in benznidazole-resistant populations of Trypanosoma cruzi and its expression is modulated by stress generated by hydrogen peroxide.

  2012cites this paper
• Distinct drug-resistant Trypanosoma cruzi clones can arise independently in a single population undergoing benznidazole-selection

  2011cites this paper
• Guidelines on the Treatment of Chronic Coinfection by Trypanosoma cruzi and HIV Outside Endemic Areas

  2011cites this paper
• Novel 3-nitro-1H-1,2,4-triazole-based aliphatic and aromatic amines as anti-chagasic agents.

  2011cites this paper
• Enfermedad de chagas crónica. Reacción de polimerasa en cadena (PCR) aplicada al diagnóstico y evaluación quimioterapéutica

  2011cites this paper
• Intracellular Bacteria and Protozoa

  2011cites this paper
• O2 consumption rates along the growth curve: new insights into Trypanosoma cruzi mitochondrial respiratory chain

  2011cites this paper
• Avaliação das perspectivas terapêuticas do ácido L-tiazolidina-4-carboxílico, um análogo de prolina, na infecção de camundongos pelo Trypanosoma cruzi.

  2011cites this paper
• Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.

  2011cites this paper
• Trypanosoma cruzi as an effective cancer antigen delivery vector

  2011cites this paper
• Synthetic Medicinal Chemistry in Chagas’ Disease: Compounds at The Final Stage of “Hit-To-Lead” Phase

  2010cites this paper
• Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.

  2010cites this paper